Last Updated on December 22, 2024 by The Health Master
USFDA approval
Leading Indian pharmaceutical company Zydus Lifesciences has secured a significant victory, receiving tentative USFDA approval from the U.S. Food and Drug Administration (USFDA) to market its generic Azilsartan Medoxomil tablets.
This medication is a crucial tool in the fight against hypertension (high blood pressure), a major public health concern.
Expanding Patient Access to Affordable Treatment
The tentative USFDA approval applies to 40mg and 80mg dosages of Azilsartan Medoxomil tablets.
This generic version offers a more cost-effective option for patients struggling with high blood pressure, potentially increasing access to this vital medication.
Zydus Lifesciences will manufacture the tablets at their state-of-the-art facility in Ahmedabad SEZ – II, India.
Combating Cardiovascular Risks
Azilsartan Medoxomil functions as an angiotensin II receptor blocker (ARB).
By working in this way, the medication helps to lower blood pressure, thereby reducing the risk of serious cardiovascular events, including:
- Stroke
- Myocardial infarction (heart attack)
Flexible Treatment Options
This USFDA approval highlights the versatility of Azilsartan Medoxomil tablets.
This medication can be prescribed alone or in combination with other antihypertensive drugs, tailoring treatment plans to individual patient needs.
A Promising Future for Azilsartan Medoxomil
Zydus Lifesciences’ achievement is a major step forward in providing patients with effective and affordable blood pressure management solutions.
With a projected USD 89 million market size in the United States (IQVIA MAT March 2024), Azilsartan Medoxomil tablets have the potential to make a significant impact on public health.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA Tentative Approval granted for Bosutinib Tablets
USFDA approval granted for this Generic Olopatadine Eye Drops
USFDA approval granted for Icatibant injection prefilled syringe
USFDA approval granted for Azilsartan Medoxomil, Chlorthalidone tablets
IPC flags side effects of heart, Glaucoma medicines
High Court: Expedite framing policy for online sale of drugs
Telangana DCA: Counterfeit Drugs Worth Rs. 23 Lakhs seized
CDSCO: Guidance document on Export NOC for Pharma Industry
Mounjaro Gets Green Light from Expert Committee for Weight Management
Chemists seek clarification on substitution of branded medicines with generics
USFDA Tentative Approval granted for Bosutinib Tablets
Govt Launches new Portal to Protect Children from Drug Abuse in India
Fake Medicine Racket Busted in Nagpur: One Arrest
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
